Chiara Tarantelli
15PUBLICATIONS
80CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Jul 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.Alberto J Arribas, Francesca Guidetti, Eleonora Cannas
|Jun 26, 2025
KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas.Chiara Tarantelli, Filippo Spriano, Elisa Civanelli
|Oct 07, 2024
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas.Alberto J Arribas, Sara Napoli, Eugenio Gaudio
|May 25, 2024
Thinking Outside the Box: Indirect Myc Modulation in Canine B-Cell Lymphoma.Luca Licenziato, Eugenio Mazzone, Chiara Tarantelli
|Feb 07, 2024
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies.Francesca Zammarchi, Karin E Havenith, Nikoleta Sachini
|Dec 05, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.Alberto J Arribas, Sara Napoli, Luciano Cascione
Pageof 3
Frequent Collaborators
13 joint publications
Francesco Bertoni
11 joint publications
Luciano Cascione
8 joint publications
Filippo Spriano
7 joint publications
Sara Napoli
7 joint publications
Emanuele Zucca
6 joint publications
Alberto J Arribas
6 joint publications
Andrea Rinaldi
5 joint publications
Georg Stussi
5 joint publications
Luca Aresu
4 joint publications
Giulio Sartori
